Clinical Trial Update: Nicotine and Sensorimotor Replacement for Smoking in Smokers With Schizophrenia [Phase 2]

View source ↗

Summary

Phase 2 trial assessing nicotine and sensorimotor replacement strategies for smoking cessation in individuals with schizophrenia; study completed with posted re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia
• Tobacco Use Disorder

Snippet

Sponsor: Brown University | Conditions: Tobacco Use Disorder, Schizophrenia | Phase 2 | Status: COMPLETED | Results posted: 2020-09-09